HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martine Calame-Christe Selected Research

DOTA- beta- Ala(3)- Nle(4)- Asp(5)- Phe(7)- Lys(10)- (111)indium-alpha-MSH (3-10)

6/2003DOTA alpha-melanocyte-stimulating hormone analogues for imaging metastatic melanoma lesions.
12/2002A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martine Calame-Christe Research Topics

Disease

4Melanoma (Melanoma, Malignant)
05/2005 - 12/2002
4Neoplasms (Cancer)
05/2005 - 12/2002
3Neoplasm Metastasis (Metastasis)
05/2005 - 06/2003
3Amelanotic Melanoma (Amelanotic Melanomas)
01/2004 - 12/2002

Drug/Important Bio-Agent (IBA)

4alpha-MSHIBA
05/2005 - 12/2002
41,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
05/2005 - 12/2002
3MelanocortinsIBA
05/2005 - 12/2002
2Lysine (L-Lysine)FDA Link
05/2005 - 01/2004
2acetyl0Nle(4)-Asp(5)-Phe(7)- alpha-MSH (4-11)IBA
05/2005 - 01/2004
2Peptides (Polypeptides)IBA
05/2005 - 01/2004
2DOTA- beta- Ala(3)- Nle(4)- Asp(5)- Phe(7)- Lys(10)- (111)indium-alpha-MSH (3-10)IBA
06/2003 - 12/2002
1Chelating AgentsIBA
05/2005
1AcidsIBA
05/2005
1MetalsIBA
05/2005
1GalliumIBA
01/2004
1RadiopharmaceuticalsIBA
06/2003
1A-factor (Streptomyces)IBA
12/2002
14-Nle-7-Phe-alpha- MSHIBA
12/2002

Therapy/Procedure

1Therapeutics
05/2005